Financial Synergies Wealth Advisors, Inc. Exelixis, Inc. Transaction History
Financial Synergies Wealth Advisors, Inc.
- $742 Billion
- Q2 2024
Shares
1 transactions
Others Institutions Holding EXEL
# of Institutions
463Shares Held
247MCall Options Held
1.7MPut Options Held
1.02M-
Black Rock Inc. New York, NY34.9MShares$816 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.8MShares$721 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA26.7MShares$624 Million2.95% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.1MShares$353 Million0.56% of portfolio
-
State Street Corp Boston, MA13.1MShares$306 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $7.53B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...